Antithrombotic Therapy in Atrial Fibrillation and Chronic Ischemic Heart Disease
-
Published:2019-05-25
Issue:5
Volume:59
Page:80-86
-
ISSN:2412-5660
-
Container-title:Kardiologiia
-
language:
-
Short-container-title:Kardiologiia
Author:
Rychkov A. Yu.1,
Khorkova N. Yu.1
Affiliation:
1. Tyumen Cardiology Research Center;
Tomsk National Research Medical Center, Russian Academy of Science
Abstract
The review is devoted to the use of antithrombotic therapy in patients with atrial fibrillation (AF) and chronic ischemic heart disease (IHD). We discuss data of international registries, meta-analyses assessing possibilities of the use of oral anticoagulants for secondary prevention of IHD. We present here results of randomized and observational clinical studies demonstrating advantages of prescription of monotherapy with oral anticoagulants (OAC) in combination of AF and chronic IHD. Modern evidence base of advantages of dual antithrombotic therapy with the use of direct OAC following percutaneous coronary intervention is also presented.
Publisher
APO Society of Specialists in Heart Failure
Subject
Cardiology and Cardiovascular Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献